NCT03268993View on ClinicalTrials.gov

Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

July 27, 2018

Primary Completion Date

July 22, 2019

Study Completion Date

July 22, 2019

Conditions
Head and Neck CancerHead and Neck Squamous Cell Carcinoma (HNSCC)Head and Neck CarcinomaHead and NeckTobacco-Related CarcinomaCarcinoma in SituDysplasiaHyperplasiaPremalignant Lesion
Interventions
DIETARY_SUPPLEMENT

Avmacol

Avmacol is a dietary supplement available over the counter

Trial Locations (2)

15213

UPMC Eye Center - Eye and Ear Institute, Pittsburgh

15232

UPMC Hillman Cancer Center, Pittsburgh

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

University of Arizona

OTHER

lead

University of Pittsburgh

OTHER

NCT03268993 - Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer | Biotech Hunter | Biotech Hunter